Navigation Links
BioProcessors Launches SimCell(TM) Services to Meet Increased Customer Demand
Date:9/26/2007

WOBURN, Mass., Sept. 26 /PRNewswire/ -- BioProcessors Corporation, a leading innovator of high-throughput cell culture-based solutions for biopharmaceutical process development, expands its Woburn operations and launches new SimCell Services offering.

"We continue to see strong interest in our SimCell technology," said Jonathan Rennert, President and CEO, BioProcessors Corporation. "The biopharmaceutical industry is accelerating its pace to clinical trials in order to identify successful therapeutic candidates sooner. Expanding our capacity and scope allows the company to respond more quickly and effectively to this key market need."

A second SimCell System was recently installed as part of an expanded laboratory and training wing at BioProcessors' Woburn facility. "Two high- throughput Robotic Systems, along with supporting analytical instrumentation and a new multi-media customer training center, provide our new team of cell culture specialists with much more comprehensive applications development and training capabilities," added Rennert. "We are now positioned to expand customer access to SimCell technology through the introduction of our new SimCell Services."

SimCell Services are customized service offerings tailored to meet specific cell culture application requirements of BioProcessors' clients. They provide access to SimCell technology through a hosted cell culture development project, which can range in scope from a simple screening experiment to more comprehensive production clone selection, clone stability, media optimization, or process development experiments. SimCell Services help clients gain better insight into their bioprocesses and reduce development risk by enabling the design of robust, optimized bioprocesses, faster and more efficiently.

About BioProcessors Corporation

BioProcessors Corporation is a developer and provider of micro-engineered solutions for cell culture-based upstream bioprocess development. T
'/>"/>

SOURCE BioProcessors Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Glaxo launches pills to help smokers quit in 7-12 weeks
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. Dr Reddy’s Laboratories launches Hyalosy
4. Serum Institute Launches New Tetanus-Diphtheria Vaccine
5. Scottish Health Minister Launches Organ Donor Plan
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
8. Pfizer Launches Viagra For Lung Disease In UK
9. PM Launches Healthcare Foundation For India
10. African Union Launches A Programme On Acceleration of HIV Prevention
11. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...enders were more likely to consider change after 3... , FRIDAY, Nov. 27 (HealthDay News) -- A ...ider why they should stop their dangerous behavior... researchers have found. , The new study includ...e-impaired convictions, who were randomly assigned...
(Date:11/28/2009)...fer tips to help lift spirits, recognize signs of ...Day News) -- For many seniors, the holiday season ...ved ones, struggle with health issues or worry abo...trics Society. , To help overcome the seasonal ...rs the following advice: , Get out and socialize...
(Date:11/27/2009)... KELOWNA, BC, Nov. 27 /PRNewswire/ - Uploadable US...g prime time in wellness. A combination of advance...pload are solving a long term concern over the acc...accurately gauge and reward improved participation...es is one of the first wellness suppliers to integ...
(Date:11/27/2009)..., DALLAS, Nov. 27 Consi...cedure only 25 years ago, solid organ transplantat...ks to the extraordinary men and women who gathered... Leaders came together from medical centers around...ylor Regional Transplant Institute (BRTI), one of ...
(Date:11/27/2009)..., ROCHESTER, N.Y., Nov. 27 /PRNewswire-USNewswire/... care provider and fortunately every year, new vac...ion. But do all vaccines boost immunity for the sa...l ,booster shots, needed to keep immunity strong? ...ournal of the American Academy of Pediatrics, Mich...
Breaking Medicine News(10 mins):Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3
She was abandoned by her biological parents a few hours after birth and left to drown in an irrigation canal in Punjab //. But the little infant survived that and has even undergone a critical heart
...urals are usually given during childbirth to ease ...o be fatal due to hospital blunders //. The Nation...sued warnings to doctors and midwives over the dru...se of the spine, but in some cases they have been ...
...s suffering from prostrate cancer can talk to doct...children, and partners - a survey result shows //....eslie D. Michelson said secret weapons for men in .... More than 27,000 men were dying every year ...
...t get misled by the looks of freeze-dried fruits. ... that the antioxidant phytochemicals //that is pre...drying. Also the benefits of these dried fruits ar...th Sciences at Ohio State University, explained ho...
...w technique was developed to test for inherited di...and healthier babies //. The British fertility cli...eds of couples hope and can test for nearly 6,000 ...ystrophy (DMD) and some forms of cystic fibrosis c...
...as been long suggested by researchers that being e... hormones and raises the chance of developing brea...ight shifts like nurses and airhostesses are consi...nmental Health Sciences, have demonstrated that lo...
Other Medicine News:Health News:Pre Implantation Genetic Haplotyping to Identify 6,000 Inherited Diseases 2Health News:Exposure To Artificial Light Could Be Cancerous 2
(Date:11/26/2009)...SBURG, South Africa, Nov. 26 The 2...he Year Award in the Generic Pharmaceutical Market.... ,, (Logo: http://www.newscom.com/cgi-bin/prn...ear Award, the following criteria were used to ben...etitors: growth strategy and implementation, degre...
(Date:11/25/2009)... Mass., Nov. 25 Hologic,... leading developer, manufacturer and supplier of p...rgical products dedicated to serving the healthcar...he Radiological Society of North America (RSNA) at...ecember 3, 2009 to highlight our new SecurView(...
(Date:11/25/2009)..., Nov. 25 BioTrends Research Group...: Stelara report, the first in a multi-phase s...nch of Centocor Ortho-Biotech,s Stelara, from prod...ility. Each wave of the report provides quantitat...qualitative information from a subset of 20. The ...
Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Signum Biosciences Awarded Phase II SBIR Grant by the NIH for the Treatment of Rosacea 4976 1Signum Biosciences Awarded Phase II SBIR Grant by the NIH for the Treatment of Rosacea 4976 2West to Present at Two Upcoming Investor Conferences 56960 1West to Present at Two Upcoming Investor Conferences 56960 2FDA Clears a Test for Ovarian Cancer 4972 1FDA Clears a Test for Ovarian Cancer 4972 2
... 2007 APA Meeting -, COLLEGEVILLE, Pa., May 21, 20...udies examining safety and efficacy of,desvenlafax...,inhibitor (SNRI) being studied as a potential tre...MDD), were presented today at the,2007 American Ps...,Calif., by Wyeth Pharmaceuticals, a division of W...
...ong-term Response at Stable Doses, According to,Ne...ATLANTA, May 22, 2007 /PRNewswire/ -- UCB announce...se Week 2007 (DDW),demonstrated long-term response... with Cimzia (certolizumab pegol), the only Fc-fre...called PRECiSE 3 (P3), is a long-term open label,c...
Other Medicine Technology:New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 2New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 3New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 4New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 5New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 6New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 7New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 8UCB Presents Long-Term CImzia Data in Crohn's Disease 2UCB Presents Long-Term CImzia Data in Crohn's Disease 3UCB Presents Long-Term CImzia Data in Crohn's Disease 4UCB Presents Long-Term CImzia Data in Crohn's Disease 5
...geable neurostimulator designed for people who do ...tenance of a rechargeable battery, for the managem... PRIMEADVANCED different from earlier generations ...h which they can be programmed to help relieve chr...
...mal matrix derived from donated human skin tissue ...ng the standards of the American Association of Ti...'s (FDA) guidelines. Since AlloDerm is regarded as... in structure from the natural material, the FDA h...
Bard CollaMend Implant
... a sterile off white, moist, tough but flexible fl...stituent elastin fibres presented moist in sterile...use in double vacuum packed aluminium foil/polyeth... is sterilised by gamma irradiation. Porcine derma...
Medicine Products: